Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas: immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a broad range of products used in the orthopaedic, surgery, cardiovascular, diabetes care and vision care fields.

Type
Public
HQ
New Brunswick, US
Founded
1886
Size (employees)
134,000 (est)+7%
Website
jnj.com
Johnson & Johnson was founded in 1886 and is headquartered in New Brunswick, US
Report incorrect company information

Key People/Management at Johnson & Johnson

Ian Davis

Ian Davis

Vice President Global Professional Affairs
Sandra Peterson

Sandra Peterson

Group Worldwide Chair
Michael Ullmann

Michael Ullmann

Executive Vice President, General Counsel
Paul Stoffels

Paul Stoffels

Executive Vice President, Chief Scientific Officer
Alex Gorsky

Alex Gorsky

Chairman, Board of Directors and Chief Executive Officer
Jorge Mesquita

Jorge Mesquita

Executive Vice President, Worldwide Chairman, Consumer
Show more

Johnson & Johnson Office Locations

Johnson & Johnson has offices in Neenah, Solothurn, Zug, Dhaka and in 24 other locations
New Brunswick, US (HQ)
One Johnson & Johnson Plaza
Greenville, US
204 Greenville Blvd SW
Solothurn, CH
21 Luzernstrasse
Zug, CH
Gubelstrasse 34, 6300
Show all (28)
Report incorrect company information

Johnson & Johnson Financials and Metrics

Johnson & Johnson Financials

Johnson & Johnson's revenue was reported to be $71.89 b in FY, 2017 which is a 2.6% increase from the previous period.
USD

Revenue (Q3, 2018)

19.7 b

Gross profit (Q3, 2018)

12.7 b

Gross profit margin (Q3, 2018), %

64.9%

Net income (Q3, 2018)

3.8 b

Market capitalization (23-Apr-2018)

348.2 b

Cash (1-Oct-2017)

15.7 b

EV

367.6 b
Johnson & Johnson's current market capitalization is $348.2 b.
Annual
USDFY, 2013FY, 2014FY, 2016FY, 2017

Revenue

71.3 b74.3 b70.1 b71.9 b

Revenue growth, %

4%(6%)3%

Cost of goods sold

22.3 b22.7 b21.5 b21.7 b

Gross profit

49 b51.6 b48.5 b50.2 b
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

17.4 b17.8 b17.1 b17.5 b18.5 b17.8 b17.8 b18.8 b19.7 b

Cost of goods sold

5.3 b5.4 b5.2 b5.3 b5.3 b5.5 b5.4 b5.8 b6.9 b

Gross profit

12.1 b12.4 b11.9 b12.2 b13.1 b12.3 b12.4 b13 b12.7 b

Gross profit Margin, %

70%70%69%70%71%69%70%69%65%
Annual
USDFY, 2013FY, 2014FY, 2016FY, 2017

Cash

20.9 b14.5 b13.7 b19 b

Accounts Receivable

11.7 b11 b10.7 b11.7 b

Prepaid Expenses

4 b3.5 b3 b3.3 b

Inventories

7.9 b8.2 b8.1 b8.1 b
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

12 b10.6 b13.6 b13.9 b18.6 b18.2 b20.9 b12.6 b15.7 b

Accounts Receivable

11.5 b12 b11.4 b11.4 b12.1 b11.8 b12.3 b13.3 b13.2 b

Prepaid Expenses

3.7 b3.1 b3 b3.3 b3.1 b2.6 b2.8 b3 b2.9 b

Inventories

8.1 b8.3 b8.2 b8.2 b8.5 b8.5 b8.9 b9.7 b9.5 b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

13.8 b16.3 b15.4 b16.5 b

Depreciation and Amortization

4.1 b3.9 b3.7 b3.8 b

Inventories

(622 m)(1.1 b)(449 m)(249 m)

Accounts Payable

1.8 b955 m(3 m)656 m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

4.3 b8.8 b12.2 b4.3 b8.5 b12.7 b4.4 b8.2 b12 b

Depreciation and Amortization

895 m1.8 b2.7 b891 m1.8 b2.7 b912 m2.1 b3.8 b

Inventories

(276 m)(537 m)(719 m)(190 m)(443 m)(408 m)(368 m)(421 m)(193 m)

Accounts Payable

(2.5 b)(2.2 b)1.6 b(2.3 b)(1 b)(1.2 b)(2 b)(1.2 b)339 m
USDY, 2017

EV/CFO

24.6 x

Revenue/Employee

155.5 k

Debt/Equity

0.5 x

Debt/Assets

0.2 x

Financial Leverage

2.1 x
Show all financial metrics

Johnson & Johnson Operating Metrics

FY, 2014FY, 2015FY, 2016FY, 2017

Manufacturing Facilities

134 121 119 125

Facilities

265 250 230 260

Countries

60 60 60 60

Discovery Projects

100 150
Show all operating metrics

Johnson & Johnson Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Lifescan (France)
Johnson & Johnson Taiwan Ltd.
Johnson & Johnson, S.A. de C.V.
Mentor Medical Systems B.V.
Omrix Biopharmaceuticals Ltd.
Penta Pty. Limited
PMC Holdings G.K.
Turnbuckle Investment Company
Acclarent
Advanced Sterilization Products Services Inc.
Show more
Report incorrect company information